Inhaled corticosteroids for asthma
Pro Research Analysisby 
Searched over 200M research papers
Inhaled Corticosteroids as First-Line Asthma Therapy
Inhaled corticosteroids (ICS) are widely recognized as the most effective treatment for controlling persistent asthma in both adults and children. They work by suppressing airway inflammation, which reduces airway hyperresponsiveness and helps control asthma symptoms. ICS are recommended as the first-line therapy for all patients with persistent asthma, as they not only improve daily symptoms but also prevent asthma exacerbations and reduce the risk of hospitalizations and mortality related to asthma 1234+3 MORE.
Mechanism of Action: Reducing Airway Inflammation
ICS suppress inflammation by switching off multiple activated inflammatory genes. This is achieved through reversing histone acetylation via the recruitment of histone deacetylase 2 (HDAC2), which leads to a reduction in the production of inflammatory mediators in the airways. This molecular action underlies the clinical improvements seen in asthma patients, including better symptom control and fewer exacerbations 15.
Efficacy in Asthma Control and Prevention
Regular use of ICS has been shown to significantly decrease asthma morbidity, including reducing the number of hospitalizations by up to 80%. There is also strong evidence that ICS reduce asthma mortality, especially when used consistently at low or conventional doses. While the evidence is less clear on whether ICS prevent long-term decline in lung function, they do reduce the risk of severe exacerbations, which are linked to more rapid lung function decline 34.
Dosing Strategies and Safety Considerations
Most of the therapeutic benefit of ICS is achieved at what is currently classified as a "low" dose (200-250 μg of fluticasone propionate or equivalent), with higher doses offering little additional benefit but increasing the risk of systemic side effects. Therefore, starting and maintaining treatment at these standard doses is recommended for most patients, with higher doses reserved for more severe cases 26.
ICS are generally safe at recommended doses, with negligible systemic side effects for most patients. However, high-dose or long-term use can lead to side effects such as impaired growth in children, osteoporosis, fractures, glaucoma, cataracts, and skin thinning. Careful dose adjustment and monitoring are important, especially in children 2910.
Pediatric Asthma: Early and Tailored ICS Use
In children, early introduction of ICS is associated with better improvement in lung function and may help prevent airway remodeling and chronic bronchial hyperreactivity. Delayed use of ICS can result in less improvement, highlighting the importance of early and tailored treatment. When doses are individually adjusted (≤400 μg daily), growth retardation is not a significant concern 910.
As-Needed and Combination ICS Therapies
For patients with mild asthma or poor adherence to daily therapy, as-needed ICS-containing therapies (such as ICS/formoterol or ICS/SABA combinations) have been shown to reduce exacerbations and improve symptom control compared to as-needed short-acting bronchodilators alone. This approach may be especially useful in real-world settings where adherence to regular therapy is low 78.
Optimizing Effectiveness: Education and Adherence
Adherence to daily ICS therapy is a key factor in achieving optimal asthma control. Education for patients and families, including demonstration of proper inhaler technique, is essential. Addressing adherence and inhaler technique can further optimize the effectiveness of ICS therapy in both adults and children .
Conclusion
Inhaled corticosteroids are the cornerstone of asthma management, offering effective control of symptoms, prevention of exacerbations, and reduction in hospitalizations and mortality. Early and appropriately dosed ICS therapy, combined with patient education and adherence support, provides the best outcomes for both adults and children with asthma. While side effects are minimal at recommended doses, ongoing monitoring and individualized treatment remain important for maximizing benefits and minimizing risks 1234+6 MORE.
Sources and full results
Most relevant research papers on this topic